A new year means that another Power List is on the horizon. The Medicine Maker annual list of the best and brightest in the pharma industry will be published in April. From academics and philanthropists, to business leaders and entrepreneurs, to technicians and regulators, everyone involved in pharma is eligible for entry. Nominations for this prestigious list will close on February 1 – and it’s up to you to decide who will be considered. Will it be dominated by returning names or will new nominees take the list by storm?
All nominations will be put to an expert judging panel who will decide on a final list that will be divided into four categories: Masters of the Bench (celebrating researchers), Business Captains (business innovation and leadership), Industry Influencers (those guiding the industry forward), and Champions of Change (those driving groundbreaking changes). To nominate, fill out the short form at http://tmm.txp.to/2018/powerlist. Or email stephanie.sutton@texerepublishing.com
Your selection may join the ranks of 2017’s illustrious winners: #1 Master of the Bench: Robert Samuel Langer; Institute Professor, Massachusetts Institute of Technology Considered one of the most prolific inventors in medicine, Robert Langer has over 1100 issued and pending patents. He previously served on the FDA’s Science Board and has been elected to the Institute of Medicine of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Inventors. #1 Industry Influencer: Richard M. Johnson; President and Chief Executive Officer, Parenteral Drug Association. “I became active in PDA 25 years ago, and this has given me the opportunity to help lead the way in promoting science-based solutions for challenges the industry faces, and to work with health authorities to improve the understanding and implementation of best practices. Serving patients is and should always be the focus of our efforts. At PDA, I am committed to working to advance our knowledge, promote best practices, and drive quality through collaboration between all stakeholders: manufacturers, suppliers and health authorities.” #1 Business Captain: Joseph Jimenez; Chief Executive Officer, Novartis. Joseph joined Novartis in April 2007 as Division Head, Novartis Consumer Health, after spending eight years running the North American, European and then Asian operations of H.J. Heinz. He was named CEO of Novartis in 2010. He is also President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Chairman Elect of Pharmaceutical Research and Manufacturers of America (PhRMA). #1 Champion of Change: Susan Desmond-Hellman; Chief Executive Officer, Bill & Melinda Gates Foundation. Trained as an oncologist, Sue spent 14 years as head of product development at Genentech – where she played a role in the development of Herceptin and Avastin – before spending five years as Chancellor of the University of California, San Francisco. You can read The Medicine Maker’s full 2017 Power List HERE
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
